Fresenius SE Long Term Debt 2016-2023 | FSNUY

Fresenius SE long term debt from 2016 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • Fresenius SE long term debt for the quarter ending September 30, 2023 was $11.860B, a 38.38% decline year-over-year.
  • Fresenius SE long term debt for 2022 was $20.004B, a 1.7% increase from 2021.
  • Fresenius SE long term debt for 2021 was $19.669B, a 2.36% increase from 2020.
  • Fresenius SE long term debt for 2020 was $19.215B, a 6.53% increase from 2019.
Fresenius SE Annual Long Term Debt
(Millions of US $)
2022 $20,004
2021 $19,669
2020 $19,215
2019 $18,036
2018 $16,581
2017 $18,246
2016 $14,212
2015 $15,109
Fresenius SE Quarterly Long Term Debt
(Millions of US $)
2023-09-30 $11,860
2023-06-30 $19,188
2023-03-31 $21,251
2022-12-31 $20,004
2022-09-30 $19,249
2022-06-30 $19,859
2022-03-31 $19,687
2021-12-31 $19,669
2021-09-30 $21,359
2021-06-30 $21,930
2021-03-31 $17,857
2020-12-31 $19,215
2020-09-30 $20,834
2020-06-30 $17,829
2020-03-31 $17,021
2019-12-31 $18,036
2019-09-30 $17,979
2019-06-30 $17,774
2019-03-31 $17,590
2018-12-31 $16,581
2018-09-30 $16,286
2018-06-30 $17,884
2018-03-31 $19,380
2017-12-31 $18,246
2017-09-30 $19,384
2017-06-30 $18,829
2017-03-31 $18,934
2016-12-31 $14,212
2016-09-30 $13,731
2016-06-30 $14,819
2016-03-31 $14,433
2015-12-31 $15,109
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.097B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.557B 16.08
DaVita (DVA) United States $11.598B 14.41
Encompass Health (EHC) United States $8.513B 21.79
Chemed (CHE) United States $8.407B 26.06
Elanco Animal Health (ELAN) United States $8.149B 21.14
Option Care Health (OPCH) United States $4.971B 18.82
RadNet (RDNT) United States $4.259B 88.69
Amedisys (AMED) United States $3.144B 22.27
LifeStance Health (LFST) United States $2.217B 0.00
Astrana Health (ASTH) United States $2.112B 28.55
Addus HomeCare (ADUS) United States $1.785B 25.54
U.S Physical Therapy (USPH) United States $1.515B 40.54
Pennant (PNTG) United States $0.681B 35.97
Aveanna Healthcare Holdings (AVAH) United States $0.521B 0.00
Atai Life Sciences (ATAI) Germany $0.273B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.016B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00